Table of Content

1 Market Overview of Long-acting Injectable Medications
1.1 Long-acting Injectable Medications Market Overview
1.1.1 Long-acting Injectable Medications Product Scope
1.1.2 Long-acting Injectable Medications Market Status and Outlook
1.2 Global Long-acting Injectable Medications Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Long-acting Injectable Medications Market Size by Region (2018-2033)
1.4 Global Long-acting Injectable Medications Historic Market Size by Region (2018-2023)
1.5 Global Long-acting Injectable Medications Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Long-acting Injectable Medications Market Size (2018-2033)
1.6.1 North America Long-acting Injectable Medications Market Size (2018-2033)
1.6.2 Europe Long-acting Injectable Medications Market Size (2018-2033)
1.6.3 Asia-Pacific Long-acting Injectable Medications Market Size (2018-2033)
1.6.4 Latin America Long-acting Injectable Medications Market Size (2018-2033)
1.6.5 Middle East & Africa Long-acting Injectable Medications Market Size (2018-2033)
2 Long-acting Injectable Medications Market by Type
2.1 Introduction
2.1.1 First-generation
2.1.2 Second-generation
2.2 Global Long-acting Injectable Medications Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Long-acting Injectable Medications Historic Market Size by Type (2018-2023)
2.2.2 Global Long-acting Injectable Medications Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Long-acting Injectable Medications Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Long-acting Injectable Medications Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Long-acting Injectable Medications Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Long-acting Injectable Medications Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Long-acting Injectable Medications Revenue Breakdown by Type (2018-2033)
3 Long-acting Injectable Medications Market Overview by Application
3.1 Introduction
3.1.1 Schizophrenia
3.1.2 Contraception
3.1.3 HIV
3.1.4 Others
3.2 Global Long-acting Injectable Medications Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Long-acting Injectable Medications Historic Market Size by Application (2018-2023)
3.2.2 Global Long-acting Injectable Medications Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Long-acting Injectable Medications Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Long-acting Injectable Medications Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Long-acting Injectable Medications Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Long-acting Injectable Medications Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Long-acting Injectable Medications Revenue Breakdown by Application (2018-2033)
4 Long-acting Injectable Medications Competition Analysis by Players
4.1 Global Long-acting Injectable Medications Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-acting Injectable Medications as of 2022)
4.3 Date of Key Players Enter into Long-acting Injectable Medications Market
4.4 Global Top Players Long-acting Injectable Medications Headquarters and Area Served
4.5 Key Players Long-acting Injectable Medications Product Solution and Service
4.6 Competitive Status
4.6.1 Long-acting Injectable Medications Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly
5.1.1 Eli Lilly Profile
5.1.2 Eli Lilly Main Business
5.1.3 Eli Lilly Long-acting Injectable Medications Products, Services and Solutions
5.1.4 Eli Lilly Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly Recent Developments
5.2 Alkermes
5.2.1 Alkermes Profile
5.2.2 Alkermes Main Business
5.2.3 Alkermes Long-acting Injectable Medications Products, Services and Solutions
5.2.4 Alkermes Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.2.5 Alkermes Recent Developments
5.3 Johnson & Johnson
5.3.1 Johnson & Johnson Profile
5.3.2 Johnson & Johnson Main Business
5.3.3 Johnson & Johnson Long-acting Injectable Medications Products, Services and Solutions
5.3.4 Johnson & Johnson Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.3.5 Zogenix Recent Developments
5.4 Zogenix
5.4.1 Zogenix Profile
5.4.2 Zogenix Main Business
5.4.3 Zogenix Long-acting Injectable Medications Products, Services and Solutions
5.4.4 Zogenix Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.4.5 Zogenix Recent Developments
5.5 DURECT
5.5.1 DURECT Profile
5.5.2 DURECT Main Business
5.5.3 DURECT Long-acting Injectable Medications Products, Services and Solutions
5.5.4 DURECT Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.5.5 DURECT Recent Developments
5.6 Mapi Pharma
5.6.1 Mapi Pharma Profile
5.6.2 Mapi Pharma Main Business
5.6.3 Mapi Pharma Long-acting Injectable Medications Products, Services and Solutions
5.6.4 Mapi Pharma Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.6.5 Mapi Pharma Recent Developments
5.7 GSK
5.7.1 GSK Profile
5.7.2 GSK Main Business
5.7.3 GSK Long-acting Injectable Medications Products, Services and Solutions
5.7.4 GSK Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.7.5 GSK Recent Developments
5.8 MedinCell
5.8.1 MedinCell Profile
5.8.2 MedinCell Main Business
5.8.3 MedinCell Long-acting Injectable Medications Products, Services and Solutions
5.8.4 MedinCell Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.8.5 MedinCell Recent Developments
5.9 Oakwood Labs
5.9.1 Oakwood Labs Profile
5.9.2 Oakwood Labs Main Business
5.9.3 Oakwood Labs Long-acting Injectable Medications Products, Services and Solutions
5.9.4 Oakwood Labs Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.9.5 Oakwood Labs Recent Developments
5.10 Nanomi
5.10.1 Nanomi Profile
5.10.2 Nanomi Main Business
5.10.3 Nanomi Long-acting Injectable Medications Products, Services and Solutions
5.10.4 Nanomi Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.10.5 Nanomi Recent Developments
5.11 Pharmathen
5.11.1 Pharmathen Profile
5.11.2 Pharmathen Main Business
5.11.3 Pharmathen Long-acting Injectable Medications Products, Services and Solutions
5.11.4 Pharmathen Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.11.5 Pharmathen Recent Developments
5.12 Kashiv BioSciences
5.12.1 Kashiv BioSciences Profile
5.12.2 Kashiv BioSciences Main Business
5.12.3 Kashiv BioSciences Long-acting Injectable Medications Products, Services and Solutions
5.12.4 Kashiv BioSciences Long-acting Injectable Medications Revenue (US$ Million) & (2018-2023)
5.12.5 Kashiv BioSciences Recent Developments
6 North America
6.1 North America Long-acting Injectable Medications Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Long-acting Injectable Medications Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Long-acting Injectable Medications Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Long-acting Injectable Medications Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Long-acting Injectable Medications Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Long-acting Injectable Medications Market Dynamics
11.1 Long-acting Injectable Medications Industry Trends
11.2 Long-acting Injectable Medications Market Drivers
11.3 Long-acting Injectable Medications Market Challenges
11.4 Long-acting Injectable Medications Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Long-acting Injectable Medications Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Long-acting Injectable Medications Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Long-acting Injectable Medications Market Size Share by Region (2018-2023)
Table 4. Global Long-acting Injectable Medications Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Long-acting Injectable Medications Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Long-acting Injectable Medications Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Long-acting Injectable Medications Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Long-acting Injectable Medications Revenue Market Share by Type (2018-2023)
Table 9. Global Long-acting Injectable Medications Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Long-acting Injectable Medications Revenue Market Share by Type (2024-2033)
Table 11. North America Long-acting Injectable Medications Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Long-acting Injectable Medications Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Long-acting Injectable Medications Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Long-acting Injectable Medications Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Long-acting Injectable Medications Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Long-acting Injectable Medications Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Long-acting Injectable Medications Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Long-acting Injectable Medications Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Long-acting Injectable Medications Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Long-acting Injectable Medications Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Long-acting Injectable Medications Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Long-acting Injectable Medications Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Long-acting Injectable Medications Revenue Market Share by Application (2018-2023)
Table 24. Global Long-acting Injectable Medications Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Long-acting Injectable Medications Revenue Market Share by Application (2024-2033)
Table 26. North America Long-acting Injectable Medications Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Long-acting Injectable Medications Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Long-acting Injectable Medications Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Long-acting Injectable Medications Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Long-acting Injectable Medications Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Long-acting Injectable Medications Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Long-acting Injectable Medications Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Long-acting Injectable Medications Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Long-acting Injectable Medications Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Long-acting Injectable Medications Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Long-acting Injectable Medications Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Long-acting Injectable Medications Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-acting Injectable Medications as of 2022)
Table 39. Date of Key Players Enter into Long-acting Injectable Medications Market
Table 40. Global Long-acting Injectable Medications Key Players Headquarters and Area Served
Table 41. Long-acting Injectable Medications Product Solution and Service
Table 42. Global Long-acting Injectable Medications Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Eli Lilly Basic Information List
Table 45. Eli Lilly Description and Business Overview
Table 46. Eli Lilly Long-acting Injectable Medications Products, Services and Solutions
Table 47. Revenue (US$ Million) in Long-acting Injectable Medications Business of Eli Lilly (2018-2023)
Table 48. Eli Lilly Recent Developments
Table 49. Alkermes Basic Information List
Table 50. Alkermes Description and Business Overview
Table 51. Alkermes Long-acting Injectable Medications Products, Services and Solutions
Table 52. Revenue (US$ Million) in Long-acting Injectable Medications Business of Alkermes (2018-2023)
Table 53. Alkermes Recent Developments
Table 54. Johnson & Johnson Basic Information List
Table 55. Johnson & Johnson Description and Business Overview
Table 56. Johnson & Johnson Long-acting Injectable Medications Products, Services and Solutions
Table 57. Revenue (US$ Million) in Long-acting Injectable Medications Business of Johnson & Johnson (2018-2023)
Table 58. Johnson & Johnson Recent Developments
Table 59. Zogenix Basic Information List
Table 60. Zogenix Description and Business Overview
Table 61. Zogenix Long-acting Injectable Medications Products, Services and Solutions
Table 62. Revenue (US$ Million) in Long-acting Injectable Medications Business of Zogenix (2018-2023)
Table 63. Zogenix Recent Developments
Table 64. DURECT Basic Information List
Table 65. DURECT Description and Business Overview
Table 66. DURECT Long-acting Injectable Medications Products, Services and Solutions
Table 67. Revenue (US$ Million) in Long-acting Injectable Medications Business of DURECT (2018-2023)
Table 68. DURECT Recent Developments
Table 69. Mapi Pharma Basic Information List
Table 70. Mapi Pharma Description and Business Overview
Table 71. Mapi Pharma Long-acting Injectable Medications Products, Services and Solutions
Table 72. Revenue (US$ Million) in Long-acting Injectable Medications Business of Mapi Pharma (2018-2023)
Table 73. Mapi Pharma Recent Developments
Table 74. GSK Basic Information List
Table 75. GSK Description and Business Overview
Table 76. GSK Long-acting Injectable Medications Products, Services and Solutions
Table 77. Revenue (US$ Million) in Long-acting Injectable Medications Business of GSK (2018-2023)
Table 78. GSK Recent Developments
Table 79. MedinCell Basic Information List
Table 80. MedinCell Description and Business Overview
Table 81. MedinCell Long-acting Injectable Medications Products, Services and Solutions
Table 82. Revenue (US$ Million) in Long-acting Injectable Medications Business of MedinCell (2018-2023)
Table 83. MedinCell Recent Developments
Table 84. Oakwood Labs Basic Information List
Table 85. Oakwood Labs Description and Business Overview
Table 86. Oakwood Labs Long-acting Injectable Medications Products, Services and Solutions
Table 87. Revenue (US$ Million) in Long-acting Injectable Medications Business of Oakwood Labs (2018-2023)
Table 88. Oakwood Labs Recent Developments
Table 89. Nanomi Basic Information List
Table 90. Nanomi Description and Business Overview
Table 91. Nanomi Long-acting Injectable Medications Products, Services and Solutions
Table 92. Revenue (US$ Million) in Long-acting Injectable Medications Business of Nanomi (2018-2023)
Table 93. Nanomi Recent Developments
Table 94. Pharmathen Basic Information List
Table 95. Pharmathen Description and Business Overview
Table 96. Pharmathen Long-acting Injectable Medications Products, Services and Solutions
Table 97. Revenue (US$ Million) in Long-acting Injectable Medications Business of Pharmathen (2018-2023)
Table 98. Pharmathen Recent Developments
Table 99. Kashiv BioSciences Basic Information List
Table 100. Kashiv BioSciences Description and Business Overview
Table 101. Kashiv BioSciences Long-acting Injectable Medications Products, Services and Solutions
Table 102. Revenue (US$ Million) in Long-acting Injectable Medications Business of Kashiv BioSciences (2018-2023)
Table 103. Kashiv BioSciences Recent Developments
Table 104. North America Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 105. North America Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 106. Europe Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 107. Europe Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 108. Asia-Pacific Long-acting Injectable Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 109. Asia-Pacific Long-acting Injectable Medications Market Size by Region (2018-2023) & (US$ Million)
Table 110. Asia-Pacific Long-acting Injectable Medications Market Size by Region (2024-2033) & (US$ Million)
Table 111. Asia-Pacific Long-acting Injectable Medications Market Share by Region (2018-2023)
Table 112. Asia-Pacific Long-acting Injectable Medications Market Share by Region (2024-2033)
Table 113. Latin America Long-acting Injectable Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 114. Latin America Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 115. Latin America Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 116. Middle East & Africa Long-acting Injectable Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 117. Middle East & Africa Long-acting Injectable Medications Market Size by Country (2018-2023) & (US$ Million)
Table 118. Middle East & Africa Long-acting Injectable Medications Market Size by Country (2024-2033) & (US$ Million)
Table 119. Long-acting Injectable Medications Market Trends
Table 120. Long-acting Injectable Medications Market Drivers
Table 121. Long-acting Injectable Medications Market Challenges
Table 122. Long-acting Injectable Medications Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-acting Injectable Medications Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Long-acting Injectable Medications Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Long-acting Injectable Medications Market Share by Regions: 2022 VS 2033
Figure 4. Global Long-acting Injectable Medications Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Long-acting Injectable Medications Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Long-acting Injectable Medications Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Long-acting Injectable Medications Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Long-acting Injectable Medications Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Long-acting Injectable Medications Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of First-generation
Figure 11. Global First-generation Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Second-generation
Figure 13. Global Second-generation Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Long-acting Injectable Medications Market Size Share by Type: 2022 & 2033
Figure 15. North America Long-acting Injectable Medications Revenue Market Share by Type (2018-2033)
Figure 16. Europe Long-acting Injectable Medications Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Long-acting Injectable Medications Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Long-acting Injectable Medications Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Long-acting Injectable Medications Revenue Market Share by Type (2018-2033)
Figure 20. Schizophrenia Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Contraception Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. HIV Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Global Long-acting Injectable Medications Market Size Share by Application: 2022 & 2033
Figure 25. North America Long-acting Injectable Medications Revenue Market Share by Application (2018-2033)
Figure 26. Europe Long-acting Injectable Medications Revenue Market Share by Application (2018-2033)
Figure 27. Asia-Pacific Long-acting Injectable Medications Revenue Market Share by Application (2018-2033)
Figure 28. Latin America Long-acting Injectable Medications Revenue Market Share by Application (2018-2033)
Figure 29. Middle East and Africa Long-acting Injectable Medications Revenue Market Share by Application (2018-2033)
Figure 30. Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Long-acting Injectable Medications Market Share in 2022
Figure 32. North America Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 33. United States Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 34. Canada Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 35. Germany Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 36. France Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 37. U.K. Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 38. Italy Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 39. Russia Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 40. Nordic Countries Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 41. Asia-Pacific Long-acting Injectable Medications Market Share by Region (2018-2033)
Figure 42. China Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 43. Japan Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 44. South Korea Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 46. India Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 47. Australia Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 48. Latin America Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 49. Mexico Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 50. Brazil Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Long-acting Injectable Medications Market Share by Country (2018-2033)
Figure 52. Turkey Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 54. UAE Long-acting Injectable Medications Market Size (2018-2033) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report